Publications:55
Harold S Kaplan, MD
About Me
Research in patient safety and establishing standardized medical event reporting for error prevention and management. Principal investigator NHLBI RO1 funded research that led to the development and implementation of an event reporting system in transfusion medicine (MERS-TM), aspects of which have been used in hospitals in the US, Canada, Ireland and Croatia, and which have been integrated into the US National Biovigilance Program. Principal investigator, AHRQ U18 grant, “Reporting Systems and Learning: Best Practices.” The resultant system, MERS-TH, has been implemented at NYPH and MSH, and is being implemented in hospitals in Rhode Island and Illinois. Principal investigator, “Patient Safety Analysis Training: DoD/AHRQ Partnership.”, and most recently, NPSF Grant, “Knowledge Discovery: The development of an error/solution matrix to improve patient safety.” Recipient in 2005 of the first AABB Hemphill-Jordan Award for work in transfusion safety. Currently serves on Advisory Editorial Board of the Pennsylvania Patient Safety Authority , Technical Expert Panel AHRQ CLABSI Project , and the NIH REDS-II Observational Study Monitoring Board. Previously chaired Patient Safety Research Coordinating Committee for AHRQ and served as temporary advisor to the WHO Challenge Group Meeting testing validity of ICPS, and on the MPSMS Technical and AHRQ Medication Safety Expert Panels.
Language
English
Position
ADJUNCT PROFESSOR | Population Health Science and Policy
Education
MD, The Albert Einstein College of Medicine
Research
Dr. Kaplan’s research interests are directed at patient safety and focused on establishing standardized medical event reporting for error prevention and management. Dr. Kaplan served as the principal investigator for NHLBI RO1 funded research that led to the development and implementation of an event reporting system in transfusion medicine (MERS-TM), aspects of which have been used in hospitals in the US, Canada, Ireland, Croatia and Spain. Additionally, core components of this system have recently been integrated into the US National Biovigilance Network program. Dr. Kaplan was honored in 2005 by the AABB for his efforts in transfusion safety with the first Hemphill-Jordan Award.
Dr. Kaplan was also principal investigator on Columbia University’s AHRQ U18 grant, “Reporting Systems and Learning: Best Practices.” which is being implemented nationally as a general medical event reporting system.
He currently serves on the Patient Safety Advisory Editorial Board of the Pennsylvania Patient Safety Authority and on the NIH REDS-III Observational Study Monitoring Board.
Publications
Selected Publications
- The Impact of Bedside Interdisciplinary Rounds on Length of Stay and Complications. Andrew S. Dunn, Maria Reyna, Brian Radbill, Michael Parides, Claudia Colgan, Tobi Osio, Ari Benson, Nicole Brown, Joy Cambe, Margo Zwerling, Natalia Egorova, Harold Kaplan. Journal of Hospital Medicine
- Managing error for system improvement. Harold S. Kaplan, James B. Battles.
- Prevalence and cost of hospital medical errors in the general and elderly United States populations. Peter J. Mallow, Bhavik Pandya, Ruslan Horblyuk, Harold S. Kaplan. Journal of Medical Economics
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Kaplan has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.